The Board of Directors of St. Christopher’s, Inc. is pleased to announce the appointment of Dr. Sarah Ruback as its new Chief Executive Officer, effective January 5, 2022. St. Christopher's is a growing, human services agency specializing in youth residential treatment and comprehensive care management services in New York.
“Dr. Ruback brings to her new role as CEO a well-rounded background in youth residential treatment services, employee growth and advancement, and new business development—expertise crucial to St. Christopher’s as we continue to expand our Agency’s human services offerings,” said Board Chair, Larry Carbone.
Dr. Ruback joined St. Christopher’s in 2016, where she has held positions of increasing scope and responsibility, most recently serving as Assistant Executive Director of Residential Services and Intra-Agency Programming. In this role, she was responsible for shaping and articulating the Agency’s strategic vision and providing leadership, management and services to more than 200 employees and residents in treatment. In this capacity, she also inaugurated the Dobbs Ferry Campus’s transition into a Therapeutic & Healing Arts Center, where movement and dance, writing, visual arts, drama, music, gardening and other therapeutic techniques are being used to enhance the well-being of residents.
“St. Christopher’s highly experienced and caring team is powered by purpose and that purpose is to help youth and families with special needs build better, stronger and more stable lives, and they deliver on that commitment every day,” said Dr. Ruback. “They are the reason I am excited and honored to assume the leadership of St. Christopher’s at this moment in time, when our trauma-informed care and services are needed more than ever, and our journey as a human services agency is evolving.”
Dr. Ruback holds a doctorate in education from Fordham University and master’s and bachelor’s degrees in fine arts from Yale University’s School of Drama and Illinois Wesleyan University, respectively. She assumed her role as CEO following the retirement of Dr. Donald Antonecchia, who led the Agency as CEO for four years.